PMID- 35036238
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220119
IS  - 2168-8184 (Print)
IS  - 2168-8184 (Electronic)
IS  - 2168-8184 (Linking)
VI  - 14
IP  - 1
DP  - 2022 Jan
TI  - Adalimumab-Induced Erythema Multiforme in a Patient With Rheumatoid Arthritis: A 
      Case Report.
PG  - e21126
LID - 10.7759/cureus.21126 [doi]
LID - e21126
AB  - Tumor necrosis factor-alpha (TNF-alpha) inhibitors are a group of biological 
      medications that revolutionized the treatment of rheumatoid arthritis (RA) and 
      several other inflammatory autoimmune diseases. The wide use of these drugs has 
      been associated with some adverse reactions. Erythema multiforme (EM) is an 
      immune-mediated cutaneous disorder that represents a hypersensitivity reaction to 
      infections, vaccines, and some medications. We present a female patient with EM 
      with characteristic skin lesions following anti-TNF-alpha medication adalimumab for 
      rheumatoid arthritis.
CI  - Copyright (c) 2022, Mohammed et al.
FAU - Mohammed, Jinan Q
AU  - Mohammed JQ
AD  - Dermatology, Basrah Teaching Hospital, Basrah, IRQ.
FAU - Mahmmod, Zainab
AU  - Mahmmod Z
AD  - Department of Medicine, College of Medicine/ University of Basrah, Basrah, IRQ.
FAU - Mathkhor, Abdulsatar J
AU  - Mathkhor AJ
AD  - Rheumatology, Basrah Teaching Hospital, Basrah, IRQ.
LA  - eng
PT  - Case Reports
DEP - 20220111
PL  - United States
TA  - Cureus
JT  - Cureus
JID - 101596737
PMC - PMC8752112
OTO - NOTNLM
OT  - adalimumab
OT  - anti-tumor necrosis factor-alpha
OT  - case report
OT  - erythema multiforme
OT  - rheumatoid arthritis
COIS- The authors have declared that no competing interests exist.
EDAT- 2022/01/18 06:00
MHDA- 2022/01/18 06:01
PMCR- 2022/01/11
CRDT- 2022/01/17 06:02
PHST- 2022/01/11 00:00 [accepted]
PHST- 2022/01/17 06:02 [entrez]
PHST- 2022/01/18 06:00 [pubmed]
PHST- 2022/01/18 06:01 [medline]
PHST- 2022/01/11 00:00 [pmc-release]
AID - 10.7759/cureus.21126 [doi]
PST - epublish
SO  - Cureus. 2022 Jan 11;14(1):e21126. doi: 10.7759/cureus.21126. eCollection 2022 
      Jan.